As the first and only PD-L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition ...
Keytruda plus platinum-based chemotherapy was found to be both safe and efficacious in treating penile squamous cell carcinoma (PSCC), according to findings from the phase 2 HERCULES trial presented ...
As the first and only PD-L1 immune checkpoint inhibitor approved for aCSCC, UNLOXCYT is an evolution in checkpoint inhibition, offering a balance of durable clinical responses and acceptable ...
Bengaluru: For years, oral cancer in India has been viewed through the lens of male tobacco use, even though women in parts ...
CorriXR Therapeutics, an oncology-focused biotherapeutics company pioneering a ground-breaking gene editing platform ...
Drug approvals this year have reflected the trend in clinical development of biologics shifting from intravenous to ...
Opdivo (nivolumab), in combination with Yervoy (ipilimumab), is indicated for the treatment of adult and paediatric patients 12 years and older with unresectable or metastatic microsatellite ...
MedPage Today on MSN
Essential Phase I Trials; Eliminating Cervical Cancer; Win for Focused Ultrasound
Phase I clinical trials remain essential for new drug development, identifying new treatment pathways, and identifying optimal dosing, the American Society of Clinical Oncology emphasized in a new ...
The following highlights showcase key research presented at the European Society for Medical Oncology (ESMO) 2025 Congress.
Sometimes, lung cancer can show itself in unexpected ways through the skin. While these skin symptoms are less common, they ...
Ficerafusp alfa 750mg QW in combination with pembrolizumab demonstrates overall response rate and safety profile consistent with the 1500mg QW ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback